MELISSA RANALLO: Open Payments
NPI 1699950345 · HUNTERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 35 payments from 15 companies in 2025. Trend: 2023 $1,001 · 2024 $885 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $75 |
| MILLICENT US INC | 4 | $73 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $60 |
| Biogen, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $48 |
| Astellas Pharma US Inc | 2 | $45 |
| Exact Sciences Corporation | 2 | $39 |
| Evofem Biosciences, Inc. | 2 | $38 |
| SHIELD THERAPEUTICS INC | 2 | $34 |
Products named: Wegovy, MYFEMBREE, ZURZUVAE, ZEPBOUND, Veozah, Cologuard Collection Kit, Phexxi, INTRAROSA.
Industry payments across NC — which companies pay providers there.
